Lataa...
Cost‐Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension
Primary aldosteronism (PA) is present in up to 20% of patients with treatment‐resistant hypertension (TRH). Investigation for PA in patients with TRH is recommended by current guidelines after medication nonadherence is excluded. Studies using therapeutic drug monitoring (TDM) have shown that >50...
Tallennettuna:
Julkaisussa: | J Clin Hypertens (Greenwich) |
---|---|
Päätekijät: | , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
John Wiley and Sons Inc.
2015
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4562815/ https://ncbi.nlm.nih.gov/pubmed/25917401 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.12570 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|